Clinical trial NCT01132443 - References

Acne Vulgaris — W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

Citation(s)

•   Terry M
  Jones, Stacy Jasper, and Alessandra B. Alió Sáenz. Phase I study: Bioavailability of clindamycin from a new clindamycin 1% - benzoyl peroxide 3% low dose gel (DUAC 3%) . Clin Pharmacol Drug Devel. 2012;2(1):

A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne Vulgaris

Details for clinical trial NCT01132443